1. Home
  2. AYTU vs ISPO Comparison

AYTU vs ISPO Comparison

Compare AYTU & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • ISPO
  • Stock Information
  • Founded
  • AYTU N/A
  • ISPO 2010
  • Country
  • AYTU United States
  • ISPO United States
  • Employees
  • AYTU N/A
  • ISPO 470
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • AYTU Health Care
  • ISPO Finance
  • Exchange
  • AYTU Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • AYTU 9.6M
  • ISPO 44.3M
  • IPO Year
  • AYTU N/A
  • ISPO N/A
  • Fundamental
  • Price
  • AYTU $2.33
  • ISPO $3.72
  • Analyst Decision
  • AYTU Strong Buy
  • ISPO
  • Analyst Count
  • AYTU 2
  • ISPO 0
  • Target Price
  • AYTU $10.00
  • ISPO N/A
  • AVG Volume (30 Days)
  • AYTU 270.5K
  • ISPO 32.4K
  • Earning Date
  • AYTU 05-14-2025
  • ISPO 08-12-2025
  • Dividend Yield
  • AYTU N/A
  • ISPO N/A
  • EPS Growth
  • AYTU N/A
  • ISPO N/A
  • EPS
  • AYTU N/A
  • ISPO N/A
  • Revenue
  • AYTU $81,659,000.00
  • ISPO $265,499,000.00
  • Revenue This Year
  • AYTU N/A
  • ISPO N/A
  • Revenue Next Year
  • AYTU $8.68
  • ISPO $148.67
  • P/E Ratio
  • AYTU N/A
  • ISPO N/A
  • Revenue Growth
  • AYTU 0.41
  • ISPO N/A
  • 52 Week Low
  • AYTU $0.95
  • ISPO $3.11
  • 52 Week High
  • AYTU $2.91
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 68.74
  • ISPO 49.55
  • Support Level
  • AYTU $2.32
  • ISPO $3.45
  • Resistance Level
  • AYTU $2.45
  • ISPO $3.87
  • Average True Range (ATR)
  • AYTU 0.12
  • ISPO 0.40
  • MACD
  • AYTU 0.02
  • ISPO -0.03
  • Stochastic Oscillator
  • AYTU 84.62
  • ISPO 25.32

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About ISPO Inspirato Incorporated

Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.

Share on Social Networks: